MicroRNA dysregulation in multiple sclerosis

84Citations
Citations of this article
133Readers
Mendeley users who have this article in their library.

Abstract

Multiple sclerosis (MS) is a chronic inflammatory disease characterized by central nervous system (CNS) demyelination and axonal degeneration. Although the cause of MS is still unknown, it is widely accepted that novel drug targets need to focus on both decreasing inflammation and promoting CNS repair. In MS and experimental autoimmune encephalomyelitis, non-coding small microRNAs (miRNAs) are dysregulated in the immune system and CNS. Since individual miRNAs are able to down-regulate multiple targeted mRNA transcripts, even minor changes in miRNA expression may lead to significant alterations in gene expression. Herein, we review miRNA signatures reported in CNS tissue and immune cells of MS patients and consider how altered miRNA expression may influence MS pathology. © 2013 de Faria O, Moore, Kennedy, Antel, Bar-Or and Dhaunchak.

Cite

CITATION STYLE

APA

de Faria, O., Moore, C. S., Kennedy, T. E., Antel, J. P., Bar-Or, A., & Dhaunchak, A. S. (2013). MicroRNA dysregulation in multiple sclerosis. Frontiers in Genetics. Frontiers Media SA. https://doi.org/10.3389/fgene.2012.00311

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free